# SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer

> **NCT04072731** · — · COMPLETED · sponsor: **People's Hospital of Zhengzhou University** · enrollment: 140 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **OTHER:** pathologic

## Key facts

- **NCT ID:** NCT04072731
- **Lead sponsor:** People's Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-16
- **Primary completion:** 2017-07-30
- **Final completion:** 2018-01-01
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072731, "SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04072731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*